• Mass Spectrometry Letters
• /
• 제12권1호
• /
• pp.1-10
• /
• 2021

A simple, specific, and economical LC-MS/MS method was investigated for the screening of 43 prescribed antihypertensive and related drugs in human urine. The urine samples were simply prepared by diluting and mixing with internal standard before directly introduced to the LC-MS/MS system, which is fast, straightforward, and cost-effective. Fractional factorial, Box-Behnken, and I-optimal design were applied to screen and optimize the mass spectrometric and chromatographic factors. The analysis was carried out on a triple quadrupole mass spectrometer system utilizing multiple reaction monitoring with positive and negative electrospray ionization method. Chromatographic separation was performed on a Thermo Scientific Accucore RP-MS column (50 × 3.0 mm ID., 2.6 ㎛) using two separate gradient elution programs established with the same mobile phases. Chromatographic separation was performed within 12 min. The optimal method was validated based on FDA guideline. The results indicated that the assay was specific, reproducible, and sensitive with the limit of detection from 0.1 to 50.0 ㎍/L. The method was linear for all analytes with coefficient of determination ranging from 0.9870 to 0.9981. The intra-assay precision was from 1.44 to 19.87% and the inter-assay precision was between 2.69 and 18.54% with the recovery rate ranges from 84.54 to 119.78% for all drugs measured. All analytes in urine samples were stable for 24 h at 25℃, and for 2 weeks at -60℃. The developed method improves on currently existing methods by including larger number of cardiovascular medications and better sensitivity of 12 analytes.

• Bulletin of the Korean Chemical Society
• /
• 제35권3호
• /
• pp.821-827
• /
• 2014

An isotope dilution liquid chromatography tandem mass spectrometry (ID LC-MS/MS) method has been developed and applied to the determination of arsenobetaine (AsB, ${(CH_3)_3}^+AsCH_2COO^-$) from oyster candidate certified reference material (CRM). The exact matching isotope dilution approach was adopted for accurate determination of AsB using $^{13}C_2$-labeled AsB as an internal standard. Efficiencies of different AsB extraction methods were evaluated using a codfish reference material and a simple sonication method was selected as the method of choice for the certification of the oyster candidate CRM. The hydrophilic interaction liquid chromatography (HILIC) combined with electrospray ionization tandem mass spectrometry (ESI/MS/MS) in selected reaction monitoring (SRM) mode was optimized for adequate chromatographic retention and robust quantification of AsB from codfish and oyster samples. By analyzing 12 subsamples taken from each 12 bottles systematically selected from the whole oyster CRM batch, the certified value of AsB was determined as $6.60mg{\cdot}kg^{-1}{\pm}0.31mg{\cdot}kg^{-1}$ and it showed excellent between-bottle homogeneity of less than 0.42%, which is represented by relative standard deviation of 12 bottles from the CRM batch. The major source of uncertainty was the certified value of the AsB standard solution.

• 분석과학
• /
• 제21권6호
• /
• pp.502-509
• /
• 2008

혈청 내 콜레스테롤을 정량분석하기 위한 일차분석법으로 동위원소희석 액체크로마토그래피/질량분석법(isotope dilution liquid chromatography/mass spectrometry)을 사용하였다. 콜레스테롤은 Thermo ODS hypersil $C^{18}$ 칼럼을 사용하여 분리하였고, 이동상은 100% 메탄올, 유속은 0.3 mL/min으로 하였다. 콜레스테롤과 콜레스테롤-$3,4-13C_2$는 $[M-H_2O+H]^+$이온에 해당하는 m/z 369.4와 371.3에서 모니터링하여 정량에 합당한 크로마토그램을 얻을 수 있었다. 방법의 유효성을 증명하기 위해서 NIST SRM 909b를 분석한 결과 인증값과 불확도 범위 내에서 일치하는 것을 확인하였다. 이 방법을 바탕으로 혈청 인증표준 물질 4 종류를 제조하여 인증을 실시하였다. 인증 결과, 반복성의 상대표준오차는 0.1~0.8%, 재현성의 경우 0.24%이하, 확장 불확도는 95% 신뢰도구간에서 약 1.43%로 나타났다.

• 분석과학
• /
• 제31권6호
• /
• pp.225-231
• /
• 2018

안식향산, 메틸파라벤, 부틸파라벤은 식품, 의약품뿐 만 아니라 화장품 분야에서도 사용되는 보존료이다. 그러나 이들 보존료들의 여러 가지 독성이 보고되면서, 한국을 비롯하여 여러 나라들에서 식품 중의 이들 보존료의 사용을 규제하고 있다. 본 연구에서는 간장 중의 안식향산, 메틸파라벤, 부틸파라벤의 정확하고 정밀한 분석을 위하여 세가지 분석물질의 동위원소를 내부표준물질로 이용하는 동위원소 희석 액체크로마토그래피 질량분석법 (Isotope Dilution Liquid Chromatography Mass Spectrometry, ID-LC/MS)을 개발하였다. 메틸, 부틸 파라벤보다 pKa가 낮은 안식향산을 고려하여 acetic acid로 pH 4.0으로 조정한 5 mM ammonium acetate를 이동상 용매로 사용하여 C18 컬럼으로 분리하였다. 질량분석 조건으로는 전기분무이온화법으로 음이온을 생성하여 음이온 모드에서 분석하였으며, 방해물질로부터 선택성을 향상하기 위해 선택반응분석법 (Selected Reaction Monitoring)을 이용하여 분석하였다. 간장의 색깔과 간장 중의 여러 가지 방해물질들을 제거하기 위하여 C18 카트리지를 이용하여 정제하였다. 최적화된 조건과 방법을 이용하여 싱가포르 Health Science Authority(HSA)가 제공하는 간장 기준시료를 분석하였다. 본 연구원에서 측정한 결과값은 HSA가 제공하는 기준값과 불확도 내에서 일치하였다.

• 분석과학
• /
• 제28권6호
• /
• pp.460-466
• /
• 2015

분유 내 콜레스테롤을 정량분석하기 위한 일차분석법으로 동위원소희석 질량분석법을 개발하였다. 내부표준물질로 콜레스테롤-d₄를 사용하여 분유에 첨가하였다. 분유에 지방산과 에스테르형태로 결합되어 있는 콜레스테롤을 자유 콜레스테롤로 바꾸어주기 위해 비누화과정을 수행하였다. 비누화과정은 반응온도, 반응시간, 사용한 KOH의 농도에 따라서 최적화하였으며, 그 결과로 분유시료 0.1 g에 대해 70 ℃에서 180 분 동안 8 M의 KOH 0.8 mL를 첨가하여 반응을 진행시키는 최적화조건을 확립하였다. 이와 같은 조건으로 실험을 진행하여 재현성은 0.23%, 확장불확도는 95%의 신뢰범위에서 1.9%로 추정되었다. 확립된 동위원소희석 질량분석법의 유효화를 위해 분유내에서 콜레스테롤의 인증값을 가지는 NIST SRM을 측정하였고 이 결과가 인증값과 불확도 범위내에서 일치하는 것을 확인하였다.

• 분석과학
• /
• 제18권4호
• /
• pp.271-277
• /
• 2005

혈액 내 urea는 임상진단 시 신장 기능을 판단하는 중요한 표지물질로서 측정되고 있다. 단백질 등 질소화합물의 최종 대사물인 urea는 콩팥의 사구체에서 걸러져 소변으로 배출되는데, 사구체의 거르는 능력이 저하되면 결국 혈액 속의 urea 농도가 증가하게 되어 신장 기능의 정상여부를 판단할 수 있게 된다. 이러한 임상진단 결과의 신뢰성 향상을 위해서는 측정결과가 일차분석법으로 인증된 인증표준 물질과 소급성 고리를 유지해야 한다. 본 연구에서는 혈청 내 urea의 일차분석법으로서 $15^N_2$-urea를 내부 표준물질로 사용하는 동위원소희석 액체크로마토그라피-질량분석법 (ID-HPLC/MS)을 개발하였다. 이 방법은 측정원리상 고도의 정확성이 확보될 뿐 아니라 별도의 유도체화가 필요 없기 때문에 빠르고 편리하다. $C_{18}$-분리관에 0.1 mmol/L $NH_4Cl$ buffer를 이동상으로 사용하여 urea를 분리하였는데, 이 완충용액은 비교적 분자량이 작은 urea를 질량분석하는데 방해가 크지 않은 장점이 있다. HPLC와 질량분석기의 인터페이스로서 positive mode의 electrospray ionization (ESI)를 사용하여 높은 감도와 재현성을 성취하였다. 국제적으로 인정된 인증표준물질의 분석을 통해 최적화된 방법의 유효성을 확인하였으며, 국제비교시험에도 참여하여 좋은 결과를 얻었다. ISO guide에 따라 불확도를 계산하였으며, 확장 불확도는 95% 신뢰도에서 약 1.8%로 나타났다. 이 분석법은 표준연에서 개발 중인 혈청인증표준물질을 인증하는 일차기준측정절차로도 사용되고 있다.

• Mass Spectrometry Letters
• /
• 제8권3호
• /
• pp.53-58
• /
• 2017

Glycated hemoglobin ($HbA_{1c}$) has been commonly used to screen and diagnose for patients with diabetes mellitus. Here the accelerated procedure of microwave-assisted sample treatment from acid hydrolysis to enzyme digestion followed by isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) was optimized and applied to measure $HbA_{1c}$ in an effort to speed up analysis time. First, two signature peptides of $HbA_{1c}$ and hemoglobin $A_0$ were certified with amino acid analysis by setting optimized acid hydrolysis conditions to $150^{\circ}C$, 1.5 h and $10{\mu}M$ sample concentration in 8 M hydrochloric acid. Consequently, the accurate certified peptides above were used as calibration standards to implement the proteolytic procedure with endoproteinase Glu-C at $37^{\circ}C$, 700 W for 6 h. Compared to the traditional method, the microwave heating not only shortened dramatically sample preparation time, but also afforded comparable recovery yields. The optimized protocol and analytical conditions in this study are suitable for a primary reference method of $HbA_{1c}$ quantification with full SI-traceability and other similar proteins in complex biological samples.

• 대한유전성대사질환학회지
• /
• 제3권1호
• /
• pp.86-93
• /
• 2003

Background : The SCL began screening of newborns and high risk group blood spots with tandem mass spectrometry (MS/MS) in April 2001. Our goal was to determine approximate prevalence of metabolic disorders, optimization of decision criteria for estimation of preventive effect with early diagnosis. This report describes the ongoing effort to identify more than 30 metabolic disorders by MS/MS in South Korea. Methods : Blood spot was collected from day 2 to 30 (mostly from day 2 to 10) after birth for newborn. Blood spot of high risk group was from the pediatric patients in NICU, developmental delay, mental retardation, strong family history of metabolic disorders. One punch (3.2 mm ID) of dried blood spots was extracted with $150{\mu}L$ of methanol containing isotopically labelled amino acids (AA) and acylcarnitines (AC) internal standards. Butanolic HCl was added and incubated at $65^{\circ}C$ for 15 min. The butylated extract was introduced into the inlet of MS/MS. Neutral loss of m/z 102 and parent ion mode of m/z 85 were set for the analyses of AA and AC, respectively. Diagnosis was confirmed by repeating acylcarnitine profile, urine organic acid and plasma amino acid analysis, direct enzyme assay, or molecular testing. Results : Approximately 31,000 neonates and children were screened and the estimated prevalence (newborn/high risk group), sensitivity, specificity and recall rate amounted to 1:2384/1:2066, 96.55%, 99.98%, and 0.73%, respectively. Confirmed 28 (0.09%) multiple metabolic disorders (newborn/high risk) were as follows; 13 amino acid disorders [classical PKU (3/4), BH4 deficient-hyperphenylalaninemia (0/1), Citrullinemia (1/0), Homocystinuria (0/2), Hypermethioninemia (0/1), Tyrosinemia (1/0)], 8 organic acidurias [Propionic aciduria (2/1), Methylmalonic aciduria (0/1), Isovaleric aciduria (1/1), 3-methylcrotonylglycineuria (1/0), Glutaric aciduria type1 (1/0)], 7 fatty acid oxidation disorders [LCHAD def. (2/2), Mitochondrial TFP def. (0/1), VLCAD def. (1/0), LC3KT def. (0/1). Conclnsion : The relatively normal development of 10 patients with metabolic disorders among newborns (except for the expired) demonstrates the usefulness of newborn screening by MS/MS for early diagnosis and medical intervention. However, close coordination between the MS/MS screening laboratory and the metabolic clinic/biochmical geneticists is needed to determine proper decision of screening parameters, confirmation diagnosis, follow-up scheme and additional tests.

• Bulletin of the Korean Chemical Society
• /
• 제31권5호
• /
• pp.1149-1154
• /
• 2010

Liquid chromatography/mass spectrometry using isotope dilution method has been established as a primary method for the measurement of cortisol in human serum. Verification of this method was accomplished by the participation in Consultative Committee for Amount of Substance-Metrology in Chemistry (CCQM) pilot study. Two levels of cortisol certified reference materials were prepared and certified by the established method. They were used as sample materials for the proficiency testing. The expanded uncertainty in the measurement of cortisol in human serum was approximately 1.2% at 95% confidence level. The results of the proficiency testing showed a good precision among the participants, but some bias to the certified values. This means that commercial field laboratories should keep traceability chain to SI unit through available reference measurement procedures and/or available reference materials.

• Bulletin of the Korean Chemical Society
• /
• 제34권6호
• /
• pp.1698-1702
• /
• 2013

Glucose is a common medical analyte measuring in human serum or blood samples. The development of a primary method is necessary for the establishment of traceability in measurements. We have developed an isotope dilution liquid chromatography tandem mass spectrometry as a primary method for the measurement of glucose in human serum. Glucose and glucose-$^{13}C_6$ in sample were ionized in ESI negative mode and monitored at mass transfers of m/z 179/89 and 185/92 in MRM, respectively. Glucose was separated on $NH_2P$-50 2D column, and the mobile phase was 20 mM $NH_4OAc$ in 30% acetonitrile/70% water. Verification of this method was performed by the comparison with NIST SRMs. Our results agreed well with the SRM values. We have developed two levels of glucose serum certified reference material using this method and distributed them to the clinical laboratories in Korea as samples for proficiency testings. The expended uncertainty was about 1.2% on 95% confidence level. In proficiency testings, the results obtained from the clinical laboratories showed about 3.6% and 3.9% RSD to the certified values. Primary method can provide the traceability to the field laboratories through proficiency testings or certified reference materials.